GSK Plc
NYSE: GSK
$33.96
+$0.26 (+0.8%)
Closing Price on November 22, 2024
GSK Articles
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
Published:
Last Updated:
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical...
Published:
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Monday, September 22, 2014.
Published:
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) released its public equity holdings as of June 30, 2014. Warren Buffett’s different portfolio holdings have not been changing much of...
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Monday, July 28, 2014. They include AcelRx Pharmaceuticals, Cisco Systems, Juniper Networks, Pfizer and Xerox.
Published:
The Department of Defense awarded $409 million in defense contracts Friday. Hewlett Packard won the day's largest award. The company will continue to providing information technology services at...
Published:
Amgen submitted an SEC Filing showing that, as of April 1, one of its subsidiaries and a GlaxoSmithKline subsidiary have terminated part and amended part of a collaboration agreement from 2009.
Published:
White House Photo by Pete SouzaAs many consider Warren Buffett to be the greatest investor of modern times, investors want to know any time there are big changes in the Berkshire Hathaway Inc. (NYSE:...
Published:
White House Photo by Pete SouzaBerkshire Hathaway Inc. (NYSE: BRK-A) and Warren Buffett have released the conglomerate’s full stock holdings as of September 30, 2013. This 13F filing with the SEC...
Published:
Jon OggEarnings season has officially started, but the stock market and bond market are both dealing with the government shutdown, an upcoming debt ceiling and even the announcement of a new Fed...
Published:
ThinkstockA malaria vaccine is supposed to be a good thing. Right? Unfortunately that all depends. GlaxoSmithKline PLC (NYSE: GSK) currently plans to seek marketing approval for the first malaria...
Published:
ThinkstockInvestors have become increasingly anxious about how badly the U.S. equity and fixed income markets will be battered as the American government marches toward a potential default. Of...
Published:
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company’s R&D operations. Since the return on research...
Published:
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top...
Published:
Last Updated:
Jon OggIt is a new week, and stocks are back in the interest of the public after recent gains. Now investors have to decide which stocks are still buys, while also determining which stocks should be...
Published: